< Back to companies
Sequential Skin

Sequential Skin

Cambridge, United Kingdom

Sequential Skin operates as a diagnostic platform specializing in skin longevity and aging through advanced genetics, epigenetics, and the skin microbiome. They provide end-to-end clinical research services for dermocosmetics, pharmaceutical, and ingredient manufacturing companies, utilizing multi-omics analysis and non-invasive sample collection. Their platform integrates wet-lab capabilities with software solutions to deliver actionable insights enabling data-driven formulation development. While offering consumer kits, they function primarily as a clinical research partner, enhancing product efficacy and consumer trust within the personal care industry.

Only accessible to MedStartr community members. Join now

Company Info

Founded
2020
Website
www.sequential.bio/

Categories

Diagnostics

Disease Areas

Technologies

Diagnostic PlatformsGenomics & Multi-OmicsBiomarkersMicrobiome Analysis
Only accessible to MedStartr community members. Join now

What do you think of Sequential Skin?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Innovation

Clinical Benefit

Feasibility

Scalability

Only accessible to MedStartr community members. Join now